Literature DB >> 32346418

Ultrasound, X-ray, computed tomography and clinical tests for diagnosis of abdominal purpura in children: A retrospective study.

Yurong Ge1, Shuchun Liu2.   

Abstract

Imaging modalities are not included in The European League Against Rheumatism, The Pediatric Rheumatology International Trials Organization and The Pediatric Rheumatology European Society 2010 criteria for the evaluation of abdominal purpura. The objective of the present study was to compare diagnostic parameters of ultrasound, X-ray and computed tomography (CT) for diagnosis of abdominal purpura considering the American College of Rheumatology (ACR) criteria as 'reference standard' in children with acute abdominal pain. Medical records of 215 children with acute abdominal pain were reviewed. Data regarding demographics and clinical characteristics, laboratory tests, X-ray, ultrasound findings, and computed tomographic images were collected and analyzed. Decision curve analysis was used for evaluation of the beneficial score for each diagnostic modality. Among diagnostic modalities, CT had the highest sensitivity (0.939); however, ultrasound findings had the highest accuracy (0.861) for diagnosis of abdominal purpura. Unlike X-ray and laboratory tests, ultrasound and CT were successful at detecting abdominal purpura when children had only colicky pain and were aged <20 years; however, occult blood stool test and granulocytes in the walls of small venules and arterioles (biopsy results) were negative. With respect to the ACR criteria, there were seven and three inconclusive results for ultrasound and CT, respectively. Abdominal ultrasound is an easy, non-invasive and safe method for the detection of abdominal purpura in children. Copyright: © Ge et al.

Entities:  

Keywords:  American College of Rheumatology criteria; X-ray; abdominal purpura; biopsy; computed tomography; occult blood stool test; ultrasound

Year:  2020        PMID: 32346418      PMCID: PMC7185176          DOI: 10.3892/etm.2020.8643

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Abdominal purpura is inflammation of systematic small vessels of unknown etiology (1) and common in individuals aged <20 years (2). It is difficult to diagnose abdominal purpura if children only have abdominal pain (3) because abdominal purpura is an acute, complex, immune-mediated vasculitis characterized by abdominal pain (4), purpuric skin lesions (5), and bloody diarrhea (6) only without thrombocytopenia (7). Differences in the clinical characteristics and pathogenesis for abdominal purpura among Xining, Tibet, inner Mongolia, and other areas were previously reported (8). According to The American College of Rheumatology (ACR) criteria, two out of four criteria (acute abdominal pain, age ≤20 years or less, bowel angina, and granulocytes in the walls of small venules and arterioles in the biopsies) must be met for diagnosis of abdominal purpura (6). These criteria have different sensitivities and specificities. Moreover, biopsies are often difficult to obtain and some patients can have atypical presentations. In addition, the age criteria are considered to be redundant (9). Lastly, imaging modalities are not used routinely in the evaluation of abdominal purpura (10). X-rays may suggest the presence of fecal impaction, an obstruction and duodenal atresia (11). Computed tomography (CT) scans of the abdomen and pelvis can provide a high yield of information (12). Ultrasound scans avoid exposure to radiation (11). There is a risk of overtreatment if children with abdominal pain are treated with steroids because steroids can cause a rapid reduction in abdominal pain but do not prevent recurrence (13). Steroids can also cause weight gain issues (4). Therefore, there is a need for non-invasive and accurate diagnostic modality for abdominal purpura. In clinical practice, it is known that abdominal ultrasound is the best approach for the correct diagnosis of abdominal complications. However, in some cases, CT can provide more detailed information. Therefore, each diagnostic technique has its specific role. The objectives of the present study were to compare diagnostic parameters of ultrasound, X-ray and CT for diagnosis of abdominal purpura, and to find additional parameters to evaluate and administer early treatment, considering ACR criteria as the ‘gold standard (reference index test)’ in children with acute abdominal pain in China.

Patients and methods

Compliance with ethical standards

The protocol of the present study was approved by the Guiyang Maternal and Child Health Hospital review board. The present study was a retrospective analysis of prospectively collected data. An informed consent form was signed by the parents of all participating children regarding diagnosis, radiology, treatment and anesthesia (if required) during hospitalization. The present study adheres to the law of China, the Strengthening the Reporting of Observational Studies in Epidemiology statement and the Declaration of Helsinki (2008).

Inclusion criteria

From January 1, 2013 to February 13, 2019, data from 227 children [109 (51%) boys and 106 (49%) girls] in the age range from 3-16 years (mean: 11.25±2.11 years) were available at the outpatient setting of Guiyang Maternal and Child Health Hospital. The children experienced acute abdominal pain or abdominal tenderness, and exhibited typical skin purpura.

Exclusion criteria

Among the available children, complete records of 12 children were not available. Therefore, they were excluded from the present study. Medical records of 215 children were included in the present analysis. A flow chart of the analysis is presented in Fig. 1.
Figure 1

Flow chart of the analysis.

Data collection

Data regarding demographical parameters, laboratory test results, X-ray, ultrasound findings, and CT images were collected of enrolled children.

Image examination

Dilatation and motility of the intestinal segments, intramural hemorrhage, and the wall of the small bowel were investigated by image examinations. X-ray and CT scans were carried out by radiologists with a minimum of 3 years of experience. Ultrasound was performed by gastroenterologists with a minimum of 3 years of experience.

Abdominal X-ray

Supine anteroposterior and/or horizontal beam (upright, decubitus or cross-Table lateral) views of abdominal X-rays (Brivo XR115; GE Healthcare) were performed at 60-75 kVp, 100 mA and 200 kHz.

Abdominal ultrasound

Abdominal ultrasound was performed using the Philip EPEQ5 5-13 MHz linear probe.

Abdominal CT

Abdominal CT was performed using the Revolution Apex scanner (GE Healthcare).

Beneficial score analysis

Decision curve analysis was used for evaluation of the beneficial score and working area for each diagnostic modality as follows: The working area is defined as the likelihood to detect abdominal purpura. Sensitivity is the ratio of the value of true positive abdominal purpura detected by imaging modality with those detected by ACR criteria. Accuracy is the ratio of the value of true negative abdominal purpura detected by imaging modality with those detected by ACR criteria.

Statistical analysis

SPSS Statistics version 25 (IBM Corp.) was used for statistical analysis. Categorical parameters are demonstrated as frequency (percentage) and continuous parameters are demonstrated as the mean ± SD. Categorical parameters were analyzed using the χ2 test or the Fisher's exact test (14) and continuous parameters were analyzed using the Wilcoxon sum rank test or the Mann-Whitney U test. P<0.05 was considered to indicate a statistically significant difference.

Results

Clinical features

In total, 99 (46%) children had abdominal tenderness located in the periumbilical area. Nausea, vomiting and diarrhea were frequent among the children. Bloody diarrhea was present in 8 (4%) children. Hematuria was observed in 18 (8%) children.

Laboratory tests

All children had an erythrocyte sedimentation rate above the normal range, 33 (15%) children had a positive occult blood stool test. All children were put on Deflazacort at 0.9 mg/kg orally once a day for 6-8 days. Other laboratory test results are presented in Table I.
Table I

Laboratory test results.

TestNormal valueTest predictionTest results
Serum amylase, IU/l23-85Abnormal135±25
Urine amylase, IU/l20-400Abnormal1,215±85
Hemoglobin, g/dl12-15Normal11.5±1.12
Total leucocyte, count/µl4,500-11,000Abnormal13,125±245
Platelet, count/µl150,000-450,000Normal353,561±7,245
Erythrocytes sedimentation rate, mm per the first hour12-20Abnormal28.12±3.45
Serum immunoglobulin A, mg/dl40-230Borderline210±35
Protein urea, mg/mmol<100  
     Positive  116(54)
     Negative  99(46)
Granulocytes in the walls of small venules and arterioles in the biopsiesN/APositive65(30)
  Negative150(70)
Occult blood stool testN/APositive33(15)
  Negative182(85)
TreatmentN/AN/ADeflazacort (0.9 mg/kg orally once a day for 6-8 days)
Onset of symptoms, daysN/AN/A7±2

Constant data are presented as ‘number (percentage)’ and continuous data are presented as the mean ± SD. n=215. N/A, not applicable.

X-ray measurements

Interior posterior views (Fig. 2A) and lateral views (Fig. 2B) of the abdomen were successful in the presentation of ileus and epididymitis (considering urinary bladder as a reference limit) but X-ray did not detect abdominal involvement where the occult blood stool test and biopsy results were negative (Fig. 2C).
Figure 2

Abdominal X-ray measurements. (A) Interior posterior X-ray view of the abdomen of a child (age 8 years). Successful in the presentation of ileus and epididymitis. (B) Lateral X-ray view of the abdomen of a child (age 8 years). Successful in the presentation of ileus and epididymitis. (C) Interior posterior X-ray view of the abdomen of a child (age 9 years). No detected abdominal involvement. The occult blood stool test and biopsy results were negative.

Ultrasound measurements

Ultrasound examinations identified thickening of the bowel wall accompanied by reduced peristalsis and dilated bowel loops. An outer hypoechoic ring from the edematous walls of the intussuscipiens was identified around an echo-dense center of the intussuceptum under ultrasound examination of empty ileum (n=85; Fig. 3A). With confirmed ileocecal intussusception, subdiaphragmatic free gas was not found on the ultrasound scan of the duodenum (n=42; Fig. 3B). However, on the outer surface of the colon, thick loops with extensive linear hemorrhages and bowel perforation were identified (n=22; Fig. 3C).
Figure 3

Abdominal ultrasound measurements. (A) Ultrasound scan of empty ileum of a child (age 8 years). Sagittal image of the abdomen. (B) Ultrasound scan of the duodenum of a child (age 8 years). Sagittal image of the abdomen. Hemorrhages (yellow arrow) and bowel perforation (white arrow) were detected. (C) Ultrasound scan of the colon of a child (age 8 years). Sagittal image of the abdomen. The hyperechoic submucosal layer (blue dots) and the hypoechoic muscularis layer (red dots) are shown.

CT measurements

Thickening of the wall and focal dilated small loop at the jejunum were detected in the abdominal CT scan (Fig. 4A). In addition, CT scans detected bowel perforation (Fig. 4B) and intussusception in abdomen (Fig. 4C).
Figure 4

Abdominal CT measurements. (A) CT scan of the abdomen of a child (age 8 years). Thickening of the wall and focal dilated small loop at the jejunum. (B) CT scan of the abdomen of a child (age 7 years). The arrow indicates bowel perforation (yellow). (C) CT scan of the abdomen of a child (age 6 years). The arrow indicates intussusception in abdomen (yellow). CT, computed tomography.

Diagnostic parameters

CT had the highest sensitivity (0.939) but ultrasound findings had the highest accuracy (0.861) among diagnostic modalities for detection of abdominal purpura. The other diagnostic parameters of imaging modalities are presented in Table II.
Table II

Diagnostic parameters.

 Diagnostic modalities measurements
 X-rayUltrasoundComputed tomography
ParametersACR criteria[a]ResultP-value[b]ResultP-value[b]ResultP-value[b]
True positive179(83)101(47)<0.0001154(72)0.006168(78)0.223[c]
True negative36(17)24(11)0.126[c]31(14)0.595[c]25(12)0.167[c]
False positive0 (0)35(16)<0.00018(4)0.0137(3)0.022
False negative0 (0)22(10)<0.000115(7)0.000212(6)0.001
Inconclusive results0 (0)33(16)<0.00017(3)0.0223(1)0.247[c]
Sensitivity10.564<0.00010.86<0.00010.939<0.0001
Accuracy10.667<0.00010.861<0.00010.694<0.0001

Constant data are presented as ‘number (percentage)’ and continuous data are presented as the mean. The χ2 independence test for constant data and the Wilcoxon sum rank test for continuous data were used for statistical analysis. P<0.05 was considered to indicate a statistically significant difference.

aACR criteria: Two among four criteria (acute abdominal pain, aged ≤20, bowel angina, and granulocytes in the walls of small venules and arterioles in the biopsies) are required for diagnosis.

bWith respect to ACR criteria.

cNon-significant difference with respect to ACR criteria. ACR, American College of Rheumatology.

X-ray findings had 0-0.75 working area to detect abdominal purpura at one time and >0.75 thresholds (only colic pain with age <20 years, absent of the other laboratory tests) there was a risk of over-diagnosis and overtreatment. Ultrasound findings had 0-0.916 working area to detect abdominal purpura at one time and >0.916 thresholds there was a risk of over-diagnosis and over-treatment. CT had 0-0.922 working area to detect abdominal purpura at one time and >0.922 thresholds there was a risk of over-diagnosis and overtreatment. Ultrasound and CT were successful at detecting abdominal purpura when children had only colic pain and were aged <20 years; however; occult blood stool test and biopsy results were absent (Fig. 5).
Figure 5

Decision curve analysis for the diagnosis of abdominal purpura. ACR criteria: Two among four criteria (acute abdominal pain, aged ≤20 years, bowel angina, and granulocytes in the walls of small venules and arterioles in the biopsies) are required for diagnosis. ACR, American College of Rheumatology.

Discussion

Laboratory tests and clinical features provide baseline information; however, do not rule out other etiologies of colicky pain, except occult blood stool test and biopsy results. However, biopsies are rarely preferred in the diagnosis of abdominal pain by physicians (15). Abdominal gastrointestinal symptoms are often observed prior to clinical symptoms (4). Ultrasound, CT and X-ray provide direct insight into visualization and detection of complications and bowel involvement (for example, bowel perforation and intussusception) (13) but imaging criteria are not used in the diagnosis of purpura (9). Even The European League Against Rheumatism, The Pediatric Rheumatology International Trials Organization and The Pediatric Rheumatology European Society 2010 criteria (15), which are the current gold standard, do not include imaging criteria for the diagnosis of abdominal purpura (4). However, imaging modalities could play an important role in the diagnosis of abdominal purpura in children. In the present study, ultrasound, CT and X-ray were successful at detecting abdominal purpura when children had colicky pain, aged <16 years, and had bowel angina. Ultrasound and CT had similar working areas but ultrasound had high accuracy among all imaging modalities. X-ray was not effective in cases where occult blood stool tests and biopsy results were negative. The results of the present study were consistent with a previous retrospective study (13) and a previous case report (3). The As Low As Reasonably Possible principle is required to maintain in the CT of children to avoid the risk of cancer (12), which is difficult to manage in children (16). Ultrasound has the ability to assess hematomas, mural thickness, small bowel intussusceptions and peritoneal fluid (3). Ultrasound provides an easy, non-invasive and safe method for the detection of abdominal purpura in children. With respect to the ACR criteria, there were seven and three inconclusive results for ultrasound and CT, respectively. Abdominal fat may interfere with proper diagnosis in imaging modalities. In addition, in non-obese Chinese children, CT resolution was as good as ultrasound (17). Thus, abdominal CT is the best method for diagnosis of abdominal purpura in Chinese children but has the issue of radiation dose. The use of an imaging method for the diagnosis of abdominal involvement in purpura presents many limitations and is only useful for some clinical presentations or complications. All children were subjected to laboratory tests with imaging modalities, which require exposure of high radiation doses. Indeed, the treatment period and treatment dose were small, yet too high for diagnosis methods. Demographical characteristics and seasons also have an impact over the diverse etiology of abdominal purpura in Chinese children (18,19); however, the present study did not consider such parameters. Erosions, mural hematoma and ulcers can be visualized by endoscopy (10). Furthermore, endoscopic examinations can be more useful in view of the pathophysiology of the disease, but endoscopy was not performed at all. Additionally, serum immunoglobulin A was not used to detect abdominal purpura in the children (9). The justification for that the level of serum immunoglobulin A is varied with age and the other demographical and clinical characters. Other limitations of the present study include the retrospective nature of the analysis and lack of a randomized trial. In conclusion, laboratory tests and clinical features do not rule out other etiologies of acute colicky pain. Ultrasound and CT had the same findings in the diagnosis of abdominal purpura; however, CT had an issue of radiation dose. Abdominal ultrasound is an easy, non-invasive and safe method for the detection of abdominal purpura.
  1 in total

1.  Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children.

Authors:  Chiara Rubino; Costanza Monacelli; Edoardo Marrani; Monica Paci; Giuseppe Indolfi; Gabriele Simonini; Sandra Trapani
Journal:  Clin Rheumatol       Date:  2021-07-17       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.